Clinical Drug Investigation

Effect of Add-On Acarbose to Insulin Therapy in Routine Clinical Practice
pp. 621-627(7)
Authors: Klocke K.R.; Stauch K.; Landen H.

Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals
pp. 629-637(9)
Authors: de Maat M.M.R.; Huitema A.D.R.; Mulder J.W.; Meenhorst P.L.; van Gorp E.C.M.; Mairuhu A.T.A.; Beijnen J.H.

Comparison of the Effects of Policosanol and Atorvastatin on Lipid Profile and Platelet Aggregation in Patients with Dyslipidaemia and Type 2 Diabetes Mellitus
pp. 639-650(12)
Authors: Castaño G.; Fernández L.; Mas R.; Illnait J.; Mesa M.; Fernández J.C.

Nimesulide versus Ibuprofen for Postoperative Tonsillectomy Pain: A Double-Blind, Randomised, Active Comparator-Controlled Clinical Trial
pp. 651-660(10)
Authors: Aho M.; Kokki H.; Nikanne E.

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs
pp. 661-670(10)
Authors: Sommerville K.W.; Dutta S.; Biton V.; Zhang Y.; Cloyd J.C.; Uthman B.

Oxcarbazepine versus Divalproex Sodium for the Continuing Treatment of Mania
pp. 671-677(7)
Authors: Reinstein M.J.; Sonnenberg J.G.; Hedberg T.G.; Jones L.E.; Reyngold P.

Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy
pp. 679-686(8)
Authors: Bachmann W.; Petzinna D.; Raptis S.A.; Wascher T.; Westermeier T.

Oxcarbazepine in Pregnancy and Lactation
pp. 687-687(1)
Author: Gentile S.